Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,858 | 218 | 71.1% |
| Travel and Lodging | $1,824 | 5 | 26.7% |
| Education | $149.96 | 3 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,485 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $585.18 | 41 | $0 (2024) |
| Cook Incorporated | $462.28 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $343.09 | 23 | $0 (2024) |
| ABIOMED | $337.95 | 15 | $0 (2024) |
| Medtronic, Inc. | $329.99 | 8 | $0 (2024) |
| Medtronic Vascular, Inc. | $276.91 | 6 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $244.67 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $188.79 | 9 | $0 (2024) |
| PFIZER INC. | $185.67 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $717.91 | 26 | ShockWave Medical, Inc ($103.48) |
| 2023 | $450.87 | 16 | Philips Electronics North America Corporation ($105.68) |
| 2022 | $233.65 | 12 | ABIOMED ($98.03) |
| 2021 | $460.47 | 13 | Edwards Lifesciences Corporation ($231.86) |
| 2020 | $212.37 | 12 | Medtronic Vascular, Inc. ($48.86) |
| 2019 | $1,158 | 69 | Janssen Pharmaceuticals, Inc ($255.54) |
| 2018 | $633.52 | 31 | Edwards Lifesciences Corporation ($104.55) |
| 2017 | $2,965 | 47 | Edwards Lifesciences Corporation ($1,919) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Philips North America LLC | (BH4) IGT Devices Undivided (Device) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Medical Device | ||||||
| 12/11/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $96.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $103.48 | General |
| Category: Lithoplasty | ||||||
| 09/27/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $37.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Rare Disease | ||||||
| 05/23/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: WATCHMAN_IC | ||||||
| 05/14/2024 | Medtronic, Inc. | V-LOC 180 (Device) | Food and Beverage | In-kind items and services | $39.71 | General |
| Category: Wound Closure | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: DIABETES | ||||||
| 04/18/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $60.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 04/10/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $13.67 | General |
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Rare Disease | ||||||
| 04/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/28/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Pacemakers | ||||||
| 03/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,888 | 2,614 | $556,223 | $131,300 |
| 2022 | 31 | 1,861 | 2,685 | $637,861 | $144,790 |
| 2021 | 34 | 1,937 | 2,638 | $613,926 | $146,946 |
| 2020 | 30 | 2,002 | 2,364 | $654,974 | $145,778 |
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 370 | 448 | $93,632 | $39,922 | 42.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 79 | 80 | $156,320 | $14,253 | 9.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 82 | 92 | $37,628 | $12,826 | 34.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 22 | 25 | $28,575 | $10,002 | 35.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 148 | $21,016 | $8,956 | 42.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 141 | 143 | $34,463 | $7,081 | 20.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 81 | 81 | $77,112 | $4,302 | 5.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 22 | 467 | $11,208 | $3,958 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 39 | $10,374 | $3,876 | 37.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 21 | 21 | $9,597 | $3,764 | 39.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 310 | 357 | $14,280 | $3,561 | 24.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 32 | 46 | $7,452 | $2,552 | 34.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,530 | $1,902 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,104 | $1,819 | 35.6% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 11 | 17 | $2,601 | $1,319 | 50.7% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 19 | 19 | $3,306 | $1,239 | 37.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 18 | $2,574 | $1,137 | 44.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 161 | 183 | $3,111 | $1,113 | 35.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 28 | $2,128 | $1,047 | 49.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 43 | 47 | $2,397 | $871.64 | 36.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 83 | 83 | $2,407 | $810.83 | 33.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 21 | 21 | $2,226 | $756.84 | 34.0% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 12 | 12 | $6,528 | $659.88 | 10.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 16 | 21 | $2,247 | $573.80 | 25.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 27 | 35 | $1,785 | $570.24 | 31.9% |
About Dr. Anil George, MD
Dr. Anil George, MD is a Cardiovascular Disease healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609073782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil George, MD has received a total of $6,832 in payments from pharmaceutical and medical device companies, with $717.91 received in 2024. These payments were reported across 226 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,858).
As a Medicare-enrolled provider, George has provided services to 7,688 Medicare beneficiaries, totaling 10,301 services with total Medicare billing of $568,814. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Syracuse, NY
- Active Since 07/02/2007
- Last Updated 03/15/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1609073782
Products in Payments
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,989
- XARELTO (Drug) $585.18
- Impella (Device) $337.95
- ENTRESTO (Drug) $302.30
- LifeVest (Device) $244.67
- ELIQUIS (Drug) $183.93
- CoreValve Evolut (Device) $181.84
- Reveal LINQ (Device) $180.51
- BRILINTA (Drug) $151.06
- Kcentra (Biological) $130.68
- (6571) Eagle Eye (Device) $105.68
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $103.48
- Vascepa (Drug) $98.82
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $98.03
- WINREVAIR (Biological) $96.89
- WATCHMAN (Device) $91.85
- Repatha (Biological) $77.23
- CardioInsight (Device) $60.40
- ANDEXXA (Biological) $59.86
- Inpefa (Drug) $46.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Syracuse
Saverio Barbera, Md, MD
Cardiovascular Disease — Payments: $41,547
Dr. Kiran Devaraj, M.d, M.D
Cardiovascular Disease — Payments: $36,432
Dr. Nikhil Joshi, M.d, M.D
Cardiovascular Disease — Payments: $28,775
Dr. Ankur Kalra, Md, MD
Cardiovascular Disease — Payments: $26,848
Dr. Tristan Petrie, Md, MD
Cardiovascular Disease — Payments: $18,178
Michael Gabris, Md Facc, MD FACC
Cardiovascular Disease — Payments: $11,834